We bring AI engineers and experts in drug R&D together to deliver relevant solutions to real-world problems. By connecting the specialized expertise of both AI experts and drug developers, we bridge the gap in expertise between these fields to cultivate a cross-field mindset that provides powerfully applicable knowledge regarding both new drug development and AI methodologies. This unique and innovative trans-field culture is key to our success.
AI changes everything!
BASIC MEDICAL RESEARCH
Focuses on therapeutic treatments and disease fighting, by establishing an understanding of cellular, molecular and physiological mechanisms, pathways and targets.
The process by which new candidate medications are discovered. This includes different approaches, such as serendipitous discovery, the high throughput screening of large compounds libraries against biological targets and more.
The process of bringing new pharmaceutical drugs to market once a lead compound has been identified through the process of drug discovery. This stage includes pre-clinical research and the various phases of clinical trials.
SUBMISSION AND REGISTRATION
Filing for regulatory status, such as for an investigational new drug, a clinical trial application or a new drug application via the United States Food and Drug Administration.
MARKETING LAUNCH AND MEDICAL AFFAIR
Aims to establish a medical strategy and platform to increase awareness of new products to enable prompt entry into the market after approval. This stage encompasses the development and execution of medical and marketing strategies, as well as tactics for a brand or therapeutic area, and requires in-depth exploration of market insights and gap analyses.
REAL WORLD EVIDENCE RESEARCH
Provides insight into how a drug performs and is used in real-world medical settings. These insights help biopharmaceutical companies rapidly improve their therapies, provide verifiable evidence, and differentiate their brands in the market.